SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. on December 6, 2023. The report discloses the issuance of a shareholder letter (Exhibit 99.1) detailing recent company developments and updates. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure of a shareholder communication rather than a financial statement.
Material Changes
No material financial changes or comparative period data are presented in the text of this filing. The primary event is the distribution of a shareholder letter regarding recent developments.
Guidance, Outlook, and Risks
The Company explicitly states it undertakes no obligation to update, supplement, or amend the materials attached as Exhibit 99.1. The information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section. Furthermore, the Company notes that the dissemination of this information is not intended to constitute a determination that the content is material or required by Regulation FD.
Key Facts for Investor Verification
- Review Exhibit 99.1 (Shareholder Letter) for specific details on recent developments, as the 8-K text only references the letter's existence.
- Confirm that the information in the shareholder letter is not incorporated by reference into other Exchange Act filings unless expressly stated.
- Note that the Company has disclaimed any obligation to update the information provided in the shareholder letter.
- Verify the trading status of BSGM on the NASDAQ Capital Market.